These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 12404665

  • 21. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].
    Tritschler L, Gaillard R, Gardier AM, David DJ, Guilloux JP.
    Encephale; 2018 Jun; 44(3):264-273. PubMed ID: 29801770
    [Abstract] [Full Text] [Related]

  • 22. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis.
    Freemantle N, Anderson IM, Young P.
    Br J Psychiatry; 2000 Oct; 177():292-302. PubMed ID: 11116769
    [Abstract] [Full Text] [Related]

  • 23. Role of norepinephrine in depression.
    Delgado PL, Moreno FA.
    J Clin Psychiatry; 2000 Oct; 61 Suppl 1():5-12. PubMed ID: 10703757
    [Abstract] [Full Text] [Related]

  • 24. The need for new and better antidepressants: reboxetine a new option.
    Dencker SJ.
    Acta Psychiatr Scand Suppl; 2000 Oct; 402():6-11. PubMed ID: 10901153
    [Abstract] [Full Text] [Related]

  • 25. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS.
    J Clin Psychiatry; 1998 Oct; 59 Suppl 14():11-4. PubMed ID: 9818625
    [Abstract] [Full Text] [Related]

  • 26. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
    Nagayasu K, Kitaichi M, Nishitani N, Asaoka N, Shirakawa H, Nakagawa T, Kaneko S.
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2295-306. PubMed ID: 23920436
    [Abstract] [Full Text] [Related]

  • 27. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF.
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [Abstract] [Full Text] [Related]

  • 28. An overview of the clinical efficacy of mirtazapine.
    Benkert O, Muller M, Szegedi A.
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [Abstract] [Full Text] [Related]

  • 29. Preclinical pharmacology of milnacipran.
    Briley M, Prost JF, Moret C.
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():9-14. PubMed ID: 8923122
    [Abstract] [Full Text] [Related]

  • 30. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
    Stahl SM.
    J Clin Psychiatry; 1998 Sep; 59 Suppl 4():5-14. PubMed ID: 9554316
    [Abstract] [Full Text] [Related]

  • 31. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [Abstract] [Full Text] [Related]

  • 32. Differences in mechanism of action between current and future antidepressants.
    Stahl SM, Grady MM.
    J Clin Psychiatry; 2003 Feb; 64 Suppl 13():13-7. PubMed ID: 14552651
    [Abstract] [Full Text] [Related]

  • 33. Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
    Eriksson E.
    Acta Psychiatr Scand Suppl; 2000 Feb; 402():12-7. PubMed ID: 10901154
    [Abstract] [Full Text] [Related]

  • 34. Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs.
    Lucki I, O'Leary OF.
    J Clin Psychiatry; 2004 Feb; 65 Suppl 4():11-24. PubMed ID: 15046537
    [Abstract] [Full Text] [Related]

  • 35. Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanisms of action.
    Potter WZ.
    J Clin Psychiatry; 1996 Feb; 57 Suppl 4():4-8. PubMed ID: 8636064
    [Abstract] [Full Text] [Related]

  • 36. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH.
    Clin Pharmacokinet; 1997 Feb; 32 Suppl 1():1-21. PubMed ID: 9068931
    [Abstract] [Full Text] [Related]

  • 37. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA, Li P.
    J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
    [Abstract] [Full Text] [Related]

  • 38. Optimizing antidepressant treatment: efficacy and tolerability.
    Deakin B, Dursun S.
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-24. PubMed ID: 12369607
    [Abstract] [Full Text] [Related]

  • 39. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
    Blier P.
    J Clin Psychiatry; 2001 Jun; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
    [Abstract] [Full Text] [Related]

  • 40. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
    Jaracz J, Rybakowski J.
    Psychiatr Pol; 2005 Jun; 39(5):937-50. PubMed ID: 16358593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.